Onyeka Ifeoma N, O'Reilly Dermot, Maguire Aideen
Centre for Public Health, Queen's University Belfast, Royal Hospitals Site, Grosvenor Road, Belfast, UK.
Administrative Data Research Centre Northern Ireland, Centre for Public Health, Queen's University Belfast, Royal Hospitals Site, Grosvenor Road, Belfast, UK.
SSM Popul Health. 2021 Feb 2;13:100749. doi: 10.1016/j.ssmph.2021.100749. eCollection 2021 Mar.
Suicide mortality and mental ill health are increasing globally. Mental ill health can be measured in multiple ways. It is unclear which measure is most associated with suicide risk. This study explored the association between self-rated mental health and medication record and death by suicide. The 2011 Northern Ireland Census records of adults aged 18-74 years (n=1,098,967) were linked to a centralised database of dispensed prescription medication and death registrations until the end of 2015. Mental health status was ascertained through both a single-item self-reported question in the Census and receipt of psychotropic medication. Logistic regression models examined the association between indicators of mental ill health and likelihood of suicide mortality. Of the 1,098,967 cohort members, 857 died by suicide during the study period. Just over half of these deaths (n=429, 50.1%) occurred in individuals with neither indicator of mental ill health. Cohort members with both self-reported mental ill health and receipt of psychotropic medication had the highest risk of suicide (OR=6.13, 95%CI: 4.94-7.61), followed by those with psychotropic medication record only (OR=4.00, 95%CI: 3.28-4.88) and self-report only (OR=2.88, 95%CI: 2.16-3.84). Individuals who report mental ill health and have a history of psychotropic medication use are at a high risk of suicide mortality. However, neither measure is particularly sensitive, as both failed to signal over half of subsequent suicides. Some individuals who report poor mental health but are not in receipt of psychotropic medication are at increased risk of suicide, indicating possible unmet treatment need. The combination of the two indicators offers more precision for identifying those most at risk for targeted interventions.
全球范围内,自杀死亡率和心理健康问题呈上升趋势。心理健康问题可以通过多种方式来衡量。目前尚不清楚哪种衡量方式与自杀风险最为相关。本研究探讨了自评心理健康状况与用药记录和自杀死亡之间的关联。将2011年北爱尔兰18 - 74岁成年人(n = 1,098,967)的人口普查记录与一个集中的处方药配药数据库以及截至2015年底的死亡登记信息进行了关联。通过人口普查中的单项自我报告问题以及精神药物的使用情况来确定心理健康状况。逻辑回归模型检验了心理健康问题指标与自杀死亡可能性之间的关联。在1,098,967名队列成员中,有857人在研究期间自杀死亡。这些死亡中,略多于一半(n = 429,50.1%)发生在没有任何心理健康问题指标的个体中。自评心理健康状况不佳且使用精神药物的队列成员自杀风险最高(OR = 6.13,95%CI:4.94 - 7.61),其次是仅有用药记录的成员(OR = 4.00,95%CI:3.28 - 4.88)以及仅自我报告的成员(OR = 2.88,95%CI:2.16 - 3.84)。报告有心理健康问题且有精神药物使用史的个体自杀死亡风险很高。然而,这两种衡量方式都不是特别敏感,因为它们都未能发现超过半数的后续自杀事件。一些报告心理健康不佳但未使用精神药物的个体自杀风险增加,这表明可能存在未满足的治疗需求。这两个指标的组合在识别最有针对性干预风险的个体方面提供了更高的准确性。